All AllTrials articles
-
Opinion
Are new drugs better than existing ones?
Should companies be made to change the way they run clinical trials?
-
Opinion
Show me the data
Making industrial safety research more transparent benefits both companies and consumers
-
Business
Cleaning up clinical trials
Campaigns to enforce complete and correct reporting of trial data are beginning to take hold
-
News
Tracker to name and shame for failure to report clinical trial results
Developers of online tool hope that it will improve accountability
-
Business
EMA finalises trial transparency rules
Researcher access reinstated, but company redaction rights may cause issues
-
Business
EMA wrangles restrain trial data progress
Attempts to balance industry and research interests on transparency draw suggestions of improper collusion
-
Business
J&J puts trial data in independent hands
Yale University’s YODA seeks to help pharma avoid the dark side by acting as gatekeeper for patient records
-
Business
GSK criticised for trial data secrecy
Italian research institute abandons collaboration over data access
-
News
AllTrials releases plan for clinical trial reporting
Public campaign sets out how trial data should be made public
-
Business
Clinical trial data release blocked by companies
Abbvie and Intermune sue the European Medicines Agency to stop it making data public
-
Business
Roche to release Tamiflu trial data
The company will drip feed data to the Cochrane Collaboration, but with some elements redacted
-
Business
GSK commits to AllTrials data disclosure
Company will begin publishing all clinical study reports